Anthony Rodgers's Publications

About Anthony Rodgers's Publications

Professorial Fellow, Professoriate
  • Professor of Global Health, Faculty of Medicine, UNSW Sydney
  • Chair of Clinical Epidemiology, Faculty of Medicine, Imperial College of London

  • Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis

    The Lancet Neurology Date published:

  • Triple and quadruple combination antihypertensive therapy in untreated individuals

    Journal of Human Hypertension Date published:

  • Association Between Follow-Up Mean Blood Pressure and Blood Pressure Control: A Meta-Regression Analysis of 101 Randomized Trials

    Hypertension Date published:

  • Triple drug antihypertensive single-pill combinations included as WHO essential medicines: an overview of efficacy, safety, and cost

    Journal of Human Hypertension Date published:

  • A Coordinated Community- and Family-Based Intervention to Control Blood Pressure in Rural China

    JACC Date published:

  • Effects of anti-calcitonin gene-related peptide medications on blood pressure in people with migraine: Review of FDA submission packages

    Cephalalgia Reports Date published:

  • Patient Preferences for Antihypertensive Medication Dispensing Trade-Offs in Cardiovascular Disease Prevention: Results From a National Survey

    Heart, Lung and Circulation Date published:

  • Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study

    The British Journal of Psychiatry Date published:

  • Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps

    Journal of Human Hypertension Date published:

  • Intensive Blood-Pressure Control for the Prevention of Major Cardiovascular Events in Patients with Type 2 Diabetes: Rationale, Design and Baseline Characteristics of the OPTIMAL-DIABETES Randomized Trial

    American Heart Journal Date published:

  • A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials

    Nature Medicine Date published:

  • Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations

    JAMA Date published:

  • Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS)

    Archives of Suicide Research Date published:

  • Efficacy and Safety of Simultaneous Initiation of SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease or Heart Failure

    JACC: Heart Failure Date published:

  • Optimising blood pressure control after stroke: established wisdom and new frontiers

    The Lancet Neurology Date published:

  • Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk

    Trials Date published: